PMA
P960004: THINLINE ENDOCARDIAL PACING LEADS
FDA PMA · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes · Boston Scientific
Key facts
| PMA number | P960004 |
|---|---|
| Trade name | THINLINE ENDOCARDIAL PACING LEADS |
| Generic name | Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes |
| Applicant | Boston Scientific |
| Owner/operator | Boston Scientific Corporation |
| Product code | NVN |
| Approval date | Nov 12, 1996 |
| Docket number | 97M-0258 |
| Notice date | Jul 2, 1997 |
| Establishment registration | 2124215 |
| FEI number | 2124215 |
At a glance
- 100–999 Supplements
- Jun 3, 2026 Latest supplement decision
- No Withdrawn
- No Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: